Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Telemedicine’s Role in Overcoming COVID-19 Healthcare Challenges

The healthcare industry has felt the ripple effects of the spread of COVID-19 perhaps more than any other – not only are healthcare providers trying to directly assist and care for patients in the wake of the disease, but supply chains, remote requirements and more have led to even more strain. However, telemedicine could provide…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Telemedicine’s Role in Overcoming COVID-19 Healthcare Challenges

The healthcare industry has felt the ripple effects of the spread of COVID-19 perhaps more than any other – not only are healthcare providers trying to directly assist and care for patients in the wake of the disease, but supply chains, remote requirements and more have led to even more strain.

However, telemedicine could provide a unique solution and help providers maintain key operational capabilities during this period of uncertainty.

The Impact of COVID-19

It’s nearly impossible to understate the disruption COVID-19, or coronavirus, has already wrought on the world’s economy, and the healthcare industry is certainly no exception.

Worldwide, the United Nations estimates that COVID-19 could cost the global economy at least $1 trillion, with some “doomsday” scenarios forecasting double that impact.

In the healthcare industry, the increased demand for masks, testing kits and personal protective equipment has strained supply chains already slowed by the very spread of the virus to key areas.

Further, the very nature of care has experience upheaval – many patients exhibiting symptoms are encouraged to self-isolate and treat those symptoms at home, yet facilities are still being tested and doctors struggling to not only provide adequate care but protect themselves and their staffs.

What is Telemedicine, and How Can It Ease Those Impacts?

Put simply, telemedicine is the practice of caring for patients remotely, most often through HIPAA-compliant videoconferencing tools that allow for unprecedented remote connections between physicians and their patients.

Clearly, this kind of remote capability can be beneficial during a pandemic such as this novel coronavirus, giving physicians a way to care for patients without endangering either themselves or other patients.

In fact, the spread of COVID-19 is driving a Renaissance of sorts in telemedicine, delivering key advantages like:

  • Extending the segment of the population that has access to beneficial screening for COVID-19
  • Easing the strain on physical healthcare facilities that could struggle to deal with the increase in demand as cases rise
  • Protecting all parties involved, including patients with other conditions who may not have COVID-19, but would be at elevated risk of severe impact if exposed to the virus
  • Providing a low-cost, simple way to provide peace of mind and proactive action when necessary

ChartLogic Doing Its Part to Encourage Telemedicine Adoption and Use

With the benefits of telemedicine during this pandemic so abundantly clear, ChartLogic has committed to helping our clients provide this service to their patients and enabling robust remote care that upholds the standards of typical, in-person care.

ChartLogic has developed a new telemedicine solution that is now available for current and new customers at no additional cost.

It’s ChartLogic’s hope that this telemedicine solution helps your practice address urgent and immediate needs created by the COVID-19 pandemic, allowing you to continue to serve your patients to the best of your ability.

To learn more and be informed when the telemedicine solution is ready for use, click here.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512